BCL2 and neoplasm: This phosphorylation prevents the binding of BTB–CUL3–RBX1 (BCR) E3 ligase to Bcl-2, thereby inhibiting the degradation of Bcl-2 and inhibiting the apoptosis of tumor cells (50).